- $5.38bn
- $23.25bn
- $2.68bn
- 60
- 77
- 86
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,017 | 2,015 | 2,088 | 2,317 | 2,685 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 847 | 894 | 1,034 | 1,910 | 1,222 |
Operating Profit | 1,170 | 1,121 | 1,054 | 407 | 1,463 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 736 | 647 | 541 | -139 | 754 |
Provision for Income Taxes | |||||
Net Income After Taxes | 587 | 516 | 437 | -97 | 615 |
Net Income Before Extraordinary Items | |||||
Net Income | 587 | 516 | 437 | -97 | 615 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 575 | 501 | 408 | -139 | 573 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.09 | 4.39 | 3.57 | 3.25 | 4.65 |
Dividends per Share |